Technical Analysis for BXN - Bioxyne Ltd
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.007 | -22.22% | -0.002 |
BXN closed down 22.22 percent on Wednesday, April 24, 2024, on 31 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
New 52 Week Closing Low | Bearish | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Narrow Range Bar | Range Contraction | -22.22% |
Alert | Time |
---|---|
Down 10% | 1 day ago |
Down 2 ATRs | 1 day ago |
Down 1 ATR | 1 day ago |
Fell Below Previous Day's Low | 1 day ago |
Down 5% | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Bioxyne Limited is an Australia-based bio-technology company engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The Company has an agreement to manufacture, market, supply and distribute its probiotic strain for over the counter dietary supplement products. Its segments include Probiotics and Other. It focuses on immune health and immunotherapeutic products. The Company's focus is on its probiotic business and product Lactobacillus fermentum PCC. The Company holds an interest in Mariposa Health Limited, a pharmaceutical development company with a focus on Congestive and Obstructive Pulmonary Disease (COPD).
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Marketing Pharmaceutical Disease Medical Specialties Therapeutic Product Therapeutic Products Bacteria Bacteriology Microbiology Over The Counter Dietary Supplement Copd Dietary Supplements Probiotic Bio Technology Digestive System Immunotherapeutic Products Pharmaceutical Development
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Marketing Pharmaceutical Disease Medical Specialties Therapeutic Product Therapeutic Products Bacteria Bacteriology Microbiology Over The Counter Dietary Supplement Copd Dietary Supplements Probiotic Bio Technology Digestive System Immunotherapeutic Products Pharmaceutical Development
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.029 |
52 Week Low | 0.007 |
Average Volume | 771,129 |
200-Day Moving Average | 0.015 |
50-Day Moving Average | 0.010 |
20-Day Moving Average | 0.009 |
10-Day Moving Average | 0.009 |
Average True Range | 0.001 |
RSI (14) | 45.05 |
ADX | 13.22 |
+DI | 25.781 |
-DI | 35.938 |
Chandelier Exit (Long, 3 ATRs) | 0.009 |
Chandelier Exit (Short, 3 ATRs) | 0.010 |
Upper Bollinger Bands | 0.012 |
Lower Bollinger Band | 0.007 |
Percent B (%b) | -0.05 |
BandWidth | 46.809 |
MACD Line | -0.001 |
MACD Signal Line | -0.001 |
MACD Histogram | 0.0 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.007 | ||||
Resistance 3 (R3) | 0.007 | 0.007 | 0.007 | ||
Resistance 2 (R2) | 0.007 | 0.007 | 0.007 | 0.007 | |
Resistance 1 (R1) | 0.007 | 0.007 | 0.007 | 0.007 | 0.007 |
Pivot Point | 0.007 | 0.007 | 0.007 | 0.007 | 0.007 |
Support 1 (S1) | 0.007 | 0.007 | 0.007 | 0.007 | 0.007 |
Support 2 (S2) | 0.007 | 0.007 | 0.007 | 0.007 | |
Support 3 (S3) | 0.007 | 0.007 | 0.007 | ||
Support 4 (S4) | 0.007 |